FDA Approves New Generic Abortion Pill as Lawsuit Moves to Missouri
- A federal judge transferred a lawsuit against the FDA regarding Mifepristone to a Missouri court, ruling some states have no ties to Texas where it was originally filed.
- The FDA approved a new generic abortion pill intended to terminate pregnancies up to 70 days, despite criticism from multiple GOP lawmakers.
- Republican Senator Josh Hawley criticized the FDA's approval of the abortion drug, stating it poses risks for mothers.
- Democratic Senator Patty Murray defended Mifepristone's safety, while former Vice President Mike Pence described the approval as a betrayal of the pro-life movement.
82 Articles
82 Articles
'Complete betrayal': Mike Pence melts down as Trump admin abandons major promise
Former Vice President Mike Pence melted down Thursday after President Donald Trump's administration approved a generic version of an abortion drug, thereby abandoning a key promise to a part of his base. The Food and Drug Administration on Thursday approved a generic version of mifepristone. The age...
Lawmakers Lay Into Trump's FDA After It Quietly Approves New Abortion Pill
Multiple GOP lawmakers blasted the Food and Drug Administration (FDA) following the agency’s greenlighting of a new abortion drug on Thursday. The flurry of criticism comes after the FDA approved of a new abortion pill from the drugmaker Evita Solutions, a company whose public mission is to “seek to normalize abortion care,” and “commit to […]


Another Generic Abortion Pill Approved Amid FDA Safety Review
(MedPage Today) -- The FDA approved a generic version of the abortion drug mifepristone produced by Evita Solutions, according to an agency letter dated Sept. 30. On its website, Evita states its mission is to assist the medical community "in...
FDA approves another generic abortion pill, prompting conservative backlash
Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.
Coverage Details
Bias Distribution
- 52% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium